Annox Capital LLC (BKNG) plans 1,000-share stock sale after prior 5,000-share trade

Rhea-AI Filing Summary

Annox Capital LLC filed to sell 1,000 shares of BKNG common stock through UBS Financial Services, Inc., with an approximate aggregate market value of $206,700.00, to be sold on or after August 5, 2026 on Nasdaq. The shares relate to a grant made to a director dated September 1, 2022. Annox Capital LLC also reports that during the past three months it sold 5,000 shares of common stock on July 29, 2026 for total proceeds of $1,000,000.00.

Key Figures

Proposed shares to be sold: 1,000 shares Approximate aggregate market value: $206,700.00 Planned sale start date: 08/05/2026 +2 more

5 metrics

Proposed shares to be sold 1,000 shares Common stock to be sold through UBS Financial Services, Inc.

Approximate aggregate market value $206,700.00 Value associated with the proposed sale of 1,000 common shares

Planned sale start date 08/05/2026 Date listed for proposed Nasdaq sales of common stock

Shares sold in past 3 months 5,000 shares Common stock sold on 07/29/2026

Proceeds from recent sale $1,000,000.00 Total proceeds from 5,000-share sale on 07/29/2026

Key Terms

Form 144, Securities To Be Sold, Securities Sold During The Past 3 Months

3 terms

Form 144 regulatory

"144: Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Securities To Be Sold regulatory

"144: Securities To Be Sold Common | 09/01/2022 | Grant made"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months Annox Capital LLC"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/05/2026 - 04:04 PM Accepted by SEC EDGAR 08/05/2026 - 04:04 PM Learn about SEC filing dates

FAQ

What does BKNG's Form 144 filing by Annox Capital LLC disclose?

The filing discloses that Annox Capital LLC plans to sell 1,000 shares of BKNG common stock, with an approximate aggregate market value of $206,700, and reports prior sales of 5,000 shares for $1,000,000 in the past three months.

How many BKNG shares are proposed for sale under this Form 144?

The Form 144 indicates a proposed sale of 1,000 shares of BKNG common stock. These shares have an approximate aggregate market value of $206,700.00 and are expected to be sold on or after August 5, 2026 on Nasdaq.

What past BKNG stock sales are reported in this Form 144?

Annox Capital LLC reports that it sold 5,000 shares of BKNG common stock on July 29, 2026 for total proceeds of $1,000,000.00. This disclosure appears in the section covering securities sold during the past three months.

What is the approximate value of BKNG shares Annox Capital LLC plans to sell?

The filing lists an approximate aggregate market value of $206,700.00 for the 1,000 shares of BKNG common stock proposed to be sold. This value is tied to the planned sales through UBS Financial Services on or after August 5, 2026.

What is the origin of the BKNG shares being sold under this Form 144?

The securities to be sold are described as a grant made to Director on September 1, 2022 by the issuer. The filing links the proposed 1,000-share sale to this director grant.

Which broker is named for the proposed BKNG share sale in the Form 144?

The filing identifies UBS Financial Services, Inc., located at Eleven Madison Avenue, 4th Floor, New York, NY 10010, as the broker involved in the proposed sale of 1,000 BKNG common shares on Nasdaq.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. Eleven Madison Avenue 4th Floor New York NY 10010	1000	206700.00	751380500	08/05/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2022	Grant made to Director	Issuer			1000	09/01/2022	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Annox Capital LLC 800 CONNECTICUT AVE Norwalk CT 06854	Common	07/29/2026	5000	1000000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)